Articles On Telix Pharmaceuticals (ASX:TLX)

Highlights A cluster of ASX 200 shares traded near multi-year lows. Earnings season created divergence between record highs and sharp pullbacks. Retail, healthcare, technology and property names faced pressure. Several...

S&P/ASX 200 Index (ASX: XJO) shares are down 1.3% at 8,925.3 points at the time of writing on Friday. The market is taking a breather after a strong week that saw the ASX 200 lift to a 14-week high of 9,043.5 points. Earnings s...

Do you have $10,000 to put into the share market and a penchant for ASX growth shares? If you do, then it could be worth considering the three named in this article that brokers rate as buys. Here's why they could be top picks: Breville Gr...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

The three ASX shares in this article are popular options for investors. But are they buys, holds, or sells? Let's see what analysts are saying about them right now: CSL Ltd (ASX: CSL) The team at Morgans thinks that this biotech giant's sh...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Updates on Conviction Calls, Best Buys and most favoured sector picks for the Februa...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Feb. 4, 2026 /PRNewswire/ — Telix Pharmace...

Telix Pharmaceuticals Ltd (ASX: TLX) shares have dropped another 2.81% in Tuesday afternoon trade. At the time of writing, the shares are changing hands at a two-year low of $10.18 a piece.  For the year-to-date the shares are now down...

When one expert thinks an ASX share is a buy, that's interesting. When numerous analysts think a business is a buy, that could be a clear indication that the business is a potential opportunity. I'm going to talk about a couple of busine...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

The Australian share market has delivered an average return in the region of 10% per annum over the long term. While this is a great return, Bell Potter thinks these ASX shares could rise materially more in 2026. Here's what it is recommend...

Highlights Australian health companies reported progress across diagnostics, therapeutics, and clinical development Research milestones and regulatory updates shaped quarterly activity in the healthcare space ASX-listed heal...

It's been a subdued start to the year for ASX stocks. The S&P/ASX 300 Index (ASX: XKO) is 1.57% higher for the year-to-date, and the S&P/ASX 200 Index (ASX: XJO) is up 1.62% as cost-of-living pressures, cash rate hike concerns and m...

A 60% share price fall in just 12 months is enough to scare off even confident investors. When it happens to a popular ASX 200 stock, it naturally raises a hard question. Is this a value opportunity, or a warning sign? In the case of Tel...

Given the sector’s travails, investors should delve into the February earnings disclosures even more diligently than usual Despite their defensive reputation, healthcare stocks have, on the whole, done poorly post pandemic In most cases, d...

The S&P/ASX 200 Index (ASX: XJO) enjoyed a euphoric start to the short trading week this Tuesday. Investors seemed to come back from the long weekend feeling refreshed and invigorated, if the share mark...

ASX surges 0.92% with nine of 11 sectors higher Strong breadth; 127 stocks rising and just 65 falling Telecoms and materials lead gains with support from banks   BHP dethrones Commonwealth Bank A broad surge in metals almost across the bo...

Highlights Materials and energy names continue to dominate market attention Sector-wide momentum reflects shifting demand and capital flows Select ASX 200 companies show renewed strength across key industries Market mo...

Highlights Strong momentum continues across key resource-led sectors Market leadership shifts reveal deeper structural trends Volatility highlights changing sentiment across major ASX groups The ASX market shows renewe...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

ASX health sector up 0.53% for the week, while broader market rises 0.36% Companies start reporting quarterly results next week ahead of half-year reporting season Third US clinical site approved for Imricor’s VISABL‑AFL trial to support U...

With February reporting season fast approaching, investors face a familiar decision. Do you wait for results and risk paying a higher price, or do you act early and accept the uncertainty that comes with buying ahead of updates? If I we...

Highlights Selected Australian listed companies operate across healthcare and technology sectors. These companies form part of broader ASX 200 and ASX 300 market benchmarks. Sector positioning reflects diverse operational mo...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin As Telix Pharmaceuticals turns the page on 2025, its annus horribilis, analysts rema...

The S&P/ASX 200 Index (ASX: XJO) closed 0.37% lower on Wednesday afternoon. For the year-to-date the index is 0.63% higher and it's 4.53% above where it was this time last year. The index hasn't posted mind-blowing gains so far this...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are sinking today. Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed yesterday trading for $11.49. During the Wednesday lunch hour, shares are chan...

 Anteris plans a US$200 million ($300 million) raising, with a “concurrent” US$90m private placement to heart device giant Medtronic Telix meets its full year guidance after a December quarter revenue surge Audeara boosts December quarter...

ASX today − Losses are gathering steam this morning, with U.S. trading starting a day later thanks to Wall Street’s Monday holiday, and it’s sending our Australian shares towards a -0.4% open when the bell rings in Sydney. Listen to the...

Shares in Telix Pharmaceuticals Ltd (ASX: TLX) will be on watch this morning after the company late yesterday revealed it had met its full year revenue guidance and had grown its fourth quarter revenue strongly. The drug developer said i...

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) was out of form again and tumbled into the red. The benchmark index dropped 0.65% to 8,815.9 points. Will the market be able to bounce back from this on Wednesday? Here are five things to w...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Ind., Jan. 20, 2026 /PRNewswire/ — Telix P...

The S&P/ASX 200 Index (ASX: XJO) is on course to record another decline. In afternoon trade, the benchmark index is down 0.6% to 8,821 points. Four ASX shares that have not let that hold them back today are listed below. Here's why the...

RBC Capital Markets says pricing and other pressures are likely to lead to subdued earnings and outlook statements A wave of CEO and CFO departures is clouding the outlook Pacific Edge is confident of regaining US Medicare coverage Invest...

Telix Pharma’s (ASX:TLX) got the Chinese market locked in its sights with a maiden application for Illuccix, a prostate cancer imaging agent, now lodged with (and accepted by) the National Medical Products Application (NMPA). Worth noting i...

Shares in Telix Pharmaceuticals Ltd (ASX: TLX) are trading higher after the company announced good news out of China for its prostate cancer imaging compound, Illuccix. The company said in a statement to the ASX on Tuesday that China's...

The Origin Energy Ltd (ASX: ORG) share price is in focus today after the company announced it will extend operations at the Eraring Power Station until April 2029, providing up to two more years of support for NSW's electricity grid and fur...

The BHP Ltd (ASX: BHP) share price is in focus today after the miner reported record copper and iron ore production for the half-year ended 31 December 2025, with copper volumes flat at 984 kt and group copper production guidance lifted for...

The HUB24 Ltd (ASX: HUB) share price is in focus today after the company reported record platform net inflows of $5.6 billion in Q2 FY26, with total Funds Under Administration (FUA) reaching $152.3 billion as at 31 December 2025, up 26% on...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ — Telix Pharmac...

The AMP Ltd (ASX: AMP) share price is in focus today after the company announced Blair Vernon will become the new Group Chief Executive Officer, with Alexis George set to retire after leading major transformation and growth since 2021. What...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus after the company announced the Chinese regulator has accepted the New Drug Application for Illuccix, Telix's lead imaging agent for prostate cancer. The pivotal Phase 3 study...

The Northern Star Resources Ltd (ASX: NST) share price is in focus after the company revised its FY26 all-in sustaining cost (AISC) guidance to A$2,600–2,800 per ounce. The gold miner also confirmed its annual production guidance will now...

I think it could be a mistake to think that the largest S&P/ASX 200 Index (ASX: XJO) growth shares have finished expanding. For starters, there are reasons why those businesses have been as successful as they have – their product/s...

Highlights Market positioning shifted quietly across energy, healthcare, and consumer names Resource-linked stocks reflected changing global demand signals Defensive and growth themes showed contrasting momentum Market...

If you are on the hunt for some of the best ASX shares to buy this month, then it could pay to listen to analysts at Bell Potter. They have revealed a number of shares that they believe are best buys right now and could offer good returns i...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ — Telix Pharmac...

I hope there is no stock market sell-off in 2026. Markets falling is never pleasant, and volatility can test even experienced investors. That said, whether markets rise steadily or stumble along the way, there are some ASX growth stocks...